# Kaiser Aluminum Corp: financial statements, quarterly

KALU · Nasdaq · CIK 811596 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kalu.md) · [Financials](/companies/kalu/financials.md) · [Filings](/companies/kalu/filings.md) · [Insiders](/companies/kalu/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kalu/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [722 d](/filings/0001193125-26-059575.md) | [738](/filings/0000950170-25-058170.md) | [773](/filings/0000950170-25-098410.md) | [748](/filings/0001193125-25-248835.md) | [765 d](/filings/0001193125-26-059575.md) | [777](/filings/0001193125-26-173882.md) | [823](/filings/0001193125-26-314580.md) | [844](/filings/0001193125-26-429090.md) | [929 d](/filings/0001193125-26-059575.md) | [1,107](/filings/0001193125-26-173882.md) | [1,257](/filings/0001193125-26-314580.md) | [1,215](/filings/0001193125-26-429090.md) |
| Cost of revenue | $m | [614 d](/filings/0001193125-26-059575.md) | [651](/filings/0000950170-25-058170.md) | [670](/filings/0000950170-25-098410.md) | [676](/filings/0001193125-25-248835.md) | [670 d](/filings/0001193125-26-059575.md) | [673](/filings/0001193125-26-173882.md) | [723](/filings/0001193125-26-314580.md) | [729](/filings/0001193125-26-429090.md) | [806 d](/filings/0001193125-26-059575.md) | [943](/filings/0001193125-26-173882.md) | [1,058](/filings/0001193125-26-314580.md) | [1,099](/filings/0001193125-26-429090.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [48.4 d](/filings/0001193125-26-059575.md) | [24.3](/filings/0000950170-25-058170.md) | [36.2](/filings/0000950170-25-098410.md) | [13.2](/filings/0001193125-25-248835.md) | [38.5 d](/filings/0001193125-26-059575.md) | [41.4](/filings/0001193125-26-173882.md) | [38.0](/filings/0001193125-26-314580.md) | [48.8](/filings/0001193125-26-429090.md) | [60.6 d](/filings/0001193125-26-059575.md) | [97.8](/filings/0001193125-26-173882.md) | [134](/filings/0001193125-26-314580.md) | [55.2](/filings/0001193125-26-429090.md) |
| Interest expense | $m | [11.5 d](/filings/0000950170-24-018958.md) | [11.5](/filings/0000950170-24-048441.md) | [11.1](/filings/0000950170-24-086678.md) | [10.7](/filings/0001193125-25-248835.md) | [10.4 d](/filings/0001193125-26-059575.md) | [11.2](/filings/0001193125-26-173882.md) | [12.5](/filings/0001193125-26-314580.md) | [12.4](/filings/0001193125-26-429090.md) | [14.0 d](/filings/0001193125-26-059575.md) | [14.4](/filings/0001193125-26-173882.md) | [14.5](/filings/0001193125-26-314580.md) | [14.2](/filings/0001193125-26-429090.md) |
| Income tax | $m | [7.2 d](/filings/0001193125-26-059575.md) | [5.5](/filings/0000950170-25-058170.md) | [5.7](/filings/0000950170-25-098410.md) | [2.4](/filings/0001193125-25-248835.md) | [8.7 d](/filings/0001193125-26-059575.md) | [7.2](/filings/0001193125-26-173882.md) | [6.7](/filings/0001193125-26-314580.md) | [8.3](/filings/0001193125-26-429090.md) | [15.3 d](/filings/0001193125-26-059575.md) | [19.9](/filings/0001193125-26-173882.md) | [29.5](/filings/0001193125-26-314580.md) | [9.2](/filings/0001193125-26-429090.md) |
| Net income | $m | [28.2 d](/filings/0001193125-26-059575.md) | [18.2](/filings/0001193125-25-248835.md) | [18.9](/filings/0001193125-25-248835.md) | [8.8](/filings/0001193125-25-248835.md) | [19.8 d](/filings/0001193125-26-059575.md) | [21.6](/filings/0001193125-26-429090.md) | [23.2](/filings/0001193125-26-429090.md) | [39.5](/filings/0001193125-26-429090.md) | [28.2 d](/filings/0001193125-26-059575.md) | [62.5](/filings/0001193125-26-429090.md) | [96.8](/filings/0001193125-26-429090.md) | [31.0](/filings/0001193125-26-429090.md) |
| Diluted EPS | $ per share | not reported | [1.12](/filings/0000950170-25-058170.md) | [1.15](/filings/0000950170-25-098410.md) | [0.54](/filings/0001193125-25-248835.md) | not reported | [1.31](/filings/0001193125-26-173882.md) | [1.41](/filings/0001193125-26-314580.md) | [2.38](/filings/0001193125-26-429090.md) | not reported | [3.71](/filings/0001193125-26-173882.md) | [5.72](/filings/0001193125-26-314580.md) | [1.84](/filings/0001193125-26-429090.md) |
| Basic EPS | $ per share | not reported | [1.13](/filings/0000950170-25-058170.md) | [1.18](/filings/0000950170-25-098410.md) | [0.54](/filings/0001193125-25-248835.md) | not reported | [1.34](/filings/0001193125-26-173882.md) | [1.44](/filings/0001193125-26-314580.md) | [2.44](/filings/0001193125-26-429090.md) | not reported | [3.85](/filings/0001193125-26-173882.md) | [5.92](/filings/0001193125-26-314580.md) | [1.90](/filings/0001193125-26-429090.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [82.4](/filings/0001193125-26-059575.md) | [102](/filings/0000950170-25-058170.md) | [70.4](/filings/0000950170-25-098410.md) | [45.7](/filings/0001193125-25-248835.md) | [18.4](/filings/0001193125-26-059575.md) | [21.3](/filings/0001193125-26-173882.md) | [13.1](/filings/0001193125-26-314580.md) | [17.2](/filings/0001193125-26-429090.md) | [7.0](/filings/0001193125-26-429090.md) | [30.0](/filings/0001193125-26-173882.md) | [58.5](/filings/0001193125-26-314580.md) | [117](/filings/0001193125-26-429090.md) |
| Current assets | $m | [990](/filings/0000950170-25-024313.md) | [1,023](/filings/0000950170-24-048441.md) | [1,011](/filings/0000950170-24-086678.md) | [995](/filings/0000950170-24-117104.md) | [1,075](/filings/0001193125-26-059575.md) | [1,094](/filings/0000950170-25-058170.md) | [1,151](/filings/0000950170-25-098410.md) | [1,244](/filings/0001193125-25-248835.md) | [1,262](/filings/0001193125-26-429090.md) | [1,487](/filings/0001193125-26-173882.md) | [1,602](/filings/0001193125-26-314580.md) | [1,615](/filings/0001193125-26-429090.md) |
| Total assets | $m | [2,267](/filings/0000950170-25-024313.md) | [2,300](/filings/0000950170-24-048441.md) | [2,316](/filings/0000950170-24-086678.md) | [2,311](/filings/0000950170-24-117104.md) | [2,410](/filings/0001193125-26-059575.md) | [2,440](/filings/0000950170-25-058170.md) | [2,513](/filings/0000950170-25-098410.md) | [2,592](/filings/0001193125-25-248835.md) | [2,565](/filings/0001193125-26-429090.md) | [2,790](/filings/0001193125-26-173882.md) | [2,910](/filings/0001193125-26-314580.md) | [2,918](/filings/0001193125-26-429090.md) |
| Current liabilities | $m | [370](/filings/0000950170-25-024313.md) | [385](/filings/0000950170-24-048441.md) | [396](/filings/0000950170-24-086678.md) | [382](/filings/0000950170-24-117104.md) | [401](/filings/0001193125-26-059575.md) | [410](/filings/0000950170-25-058170.md) | [426](/filings/0000950170-25-098410.md) | [501](/filings/0001193125-25-248835.md) | [427](/filings/0001193125-26-429090.md) | [602](/filings/0001193125-26-173882.md) | [642](/filings/0001193125-26-314580.md) | [615](/filings/0001193125-26-429090.md) |
| Total liabilities | $m | [1,615](/filings/0000950170-25-024313.md) | [1,635](/filings/0000950170-24-048441.md) | [1,654](/filings/0000950170-24-086678.md) | [1,644](/filings/0000950170-24-117104.md) | [1,667](/filings/0001193125-26-059575.md) | [1,683](/filings/0000950170-25-058170.md) | [1,737](/filings/0000950170-25-098410.md) | [1,786](/filings/0001193125-25-248835.md) | [1,739](/filings/0001193125-26-429090.md) | [1,913](/filings/0001193125-26-173882.md) | [1,966](/filings/0001193125-26-314580.md) | [1,943](/filings/0001193125-26-429090.md) |
| Long-term debt | $m | [1,040](/filings/0000950170-25-024313.md) | [1,040](/filings/0000950170-24-048441.md) | [1,041](/filings/0000950170-24-086678.md) | [1,041](/filings/0000950170-24-117104.md) | [1,042](/filings/0001193125-26-059575.md) | [1,042](/filings/0000950170-25-058170.md) | [1,075](/filings/0000950170-25-098410.md) | [1,043](/filings/0001193125-25-248835.md) | [1,060](/filings/0001193125-26-429090.md) | [1,038](/filings/0001193125-26-173882.md) | [1,038](/filings/0001193125-26-314580.md) | [1,039](/filings/0001193125-26-429090.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [708](/filings/0001193125-26-059575.md) | [715](/filings/0001193125-25-248835.md) | [728](/filings/0001193125-25-248835.md) | [729](/filings/0001193125-25-248835.md) | [743](/filings/0001193125-26-429090.md) | [757](/filings/0001193125-26-429090.md) | [776](/filings/0001193125-26-429090.md) | [806](/filings/0001193125-26-429090.md) | [826](/filings/0001193125-26-429090.md) | [877](/filings/0001193125-26-429090.md) | [944](/filings/0001193125-26-429090.md) | [976](/filings/0001193125-26-429090.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [74.3 d](/filings/0001193125-26-059575.md) | [63.3](/filings/0000950170-25-058170.md) | [26.3 d](/filings/0000950170-25-098410.md) | [34.1 d](/filings/0001193125-25-248835.md) | [43.4 d](/filings/0001193125-26-059575.md) | [57.0](/filings/0001193125-26-173882.md) | [15.9 d](/filings/0001193125-26-314580.md) | [59.1 d](/filings/0001193125-26-429090.md) | [(20.6) d](/filings/0001193125-26-059575.md) | [87.9](/filings/0001193125-26-173882.md) | [59.5 d](/filings/0001193125-26-314580.md) | [101 d](/filings/0001193125-26-429090.md) |
| Capital expenditure | $m | [23.2 d](/filings/0001193125-26-059575.md) | [30.0](/filings/0000950170-25-058170.md) | [43.7 d](/filings/0000950170-25-098410.md) | [51.1 d](/filings/0001193125-25-248835.md) | [56.0 d](/filings/0001193125-26-059575.md) | [38.2](/filings/0001193125-26-173882.md) | [43.6 d](/filings/0001193125-26-314580.md) | [24.6 d](/filings/0001193125-26-429090.md) | [30.5 d](/filings/0001193125-26-059575.md) | [19.4](/filings/0001193125-26-173882.md) | [24.4 d](/filings/0001193125-26-314580.md) | [28.4 d](/filings/0001193125-26-429090.md) |
| Dividends paid | $m | [12.7 d](/filings/0001193125-26-059575.md) | [12.6](/filings/0000950170-25-058170.md) | [12.7 d](/filings/0000950170-25-098410.md) | [12.7 d](/filings/0001193125-25-248835.md) | [12.7 d](/filings/0001193125-26-059575.md) | [12.9](/filings/0001193125-26-173882.md) | [12.8 d](/filings/0001193125-26-314580.md) | [12.8 d](/filings/0001193125-26-429090.md) | [12.8 d](/filings/0001193125-26-059575.md) | [13.6](/filings/0001193125-26-173882.md) | [12.8 d](/filings/0001193125-26-314580.md) | [12.8 d](/filings/0001193125-26-429090.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [16.1](/filings/0000950170-24-048441.md) | [16.1](/filings/0000950170-24-086678.md) | [16.2](/filings/0000950170-24-117104.md) | [16.2](/filings/0000950170-25-058170.md) | [16.4](/filings/0000950170-25-098410.md) | [16.3](/filings/0001193125-25-248835.md) | [16.4](/filings/0001193125-26-173882.md) | [16.5](/filings/0001193125-26-314580.md) | [16.6](/filings/0001193125-26-429090.md) | [16.8](/filings/0001193125-26-173882.md) | [16.9](/filings/0001193125-26-314580.md) | [16.9](/filings/0001193125-26-429090.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 16,349,886 at 2026-10-19, from the cover of the [10-Q filed 2026-10-22](/filings/0001193125-26-429090.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.